AT454886T - Matrix preparations for the controlled administration of drug substances - Google Patents

Matrix preparations for the controlled administration of drug substances

Info

Publication number
AT454886T
AT454886T AT08158752T AT08158752T AT454886T AT 454886 T AT454886 T AT 454886T AT 08158752 T AT08158752 T AT 08158752T AT 08158752 T AT08158752 T AT 08158752T AT 454886 T AT454886 T AT 454886T
Authority
AT
Austria
Prior art keywords
drug substances
controlled administration
matrix preparations
preparations
matrix
Prior art date
Application number
AT08158752T
Other languages
German (de)
Inventor
Daniel Bar-Shalom
Gina Fischer
Lillian Slot
Anne-Marie Lademann
Original Assignee
Egalet As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DKPA200300464 priority Critical
Priority to PCT/DK2003/000765 priority patent/WO2004041252A1/en
Application filed by Egalet As filed Critical Egalet As
Publication of AT454886T publication Critical patent/AT454886T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules, nanotubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893Tablet coating processes
AT08158752T 2002-11-08 2004-03-26 Matrix preparations for the controlled administration of drug substances AT454886T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DKPA200300464 2003-03-26
PCT/DK2003/000765 WO2004041252A1 (en) 2002-11-08 2003-11-07 Controlled release carvedilol compositions

Publications (1)

Publication Number Publication Date
AT454886T true AT454886T (en) 2010-01-15

Family

ID=33099580

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08158752T AT454886T (en) 2002-11-08 2004-03-26 Matrix preparations for the controlled administration of drug substances
AT04723523T AT399538T (en) 2002-11-08 2004-03-26 Matrix preparations for the controlled administration of drug substances

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04723523T AT399538T (en) 2002-11-08 2004-03-26 Matrix preparations for the controlled administration of drug substances

Country Status (9)

Country Link
US (2) US8298581B2 (en)
EP (3) EP1610768B1 (en)
JP (1) JP4989217B2 (en)
AT (2) AT454886T (en)
CA (1) CA2520312C (en)
DE (2) DE602004025159D1 (en)
DK (1) DK1610768T3 (en)
ES (1) ES2307003T3 (en)
WO (1) WO2004084869A1 (en)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT267589T (en) * 1998-04-03 2004-06-15 Egalet As A composition with controlled active ingredient release
DE10026698A1 (en) * 2000-05-30 2001-12-06 Basf Ag Self-emulsifying drug formulation and use of this formulation
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
EP1429744A1 (en) 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
AT454886T (en) * 2003-03-26 2010-01-15 Egalet As Matrix preparations for the controlled administration of drug substances
WO2004041252A1 (en) * 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
EP2301526B1 (en) * 2003-03-26 2016-03-23 Egalet Ltd. Morphine controlled release system
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Abuse-proofed dosage form
US8025899B2 (en) * 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
DE102004032051A1 (en) 2004-07-01 2006-01-19 Grünenthal GmbH A process for preparing a secured against misuse, solid dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Unbreakable dosage forms with delayed release
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
CN101188999B (en) * 2005-06-03 2012-07-18 尹格莱特股份有限公司 A pharmaceutical delivery system for delivering active component dispersed in dispersion medium
US9198865B2 (en) * 2006-01-19 2015-12-01 Dow Global Technologies Llc Biologically active composition comprising ethylcellulose
CA2674536C (en) * 2007-01-16 2016-07-26 Egalet A/S Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
DE102007011485A1 (en) 2007-03-07 2008-09-11 Grünenthal GmbH Dosage form with impeded abuse
KR100932613B1 (en) * 2007-04-27 2009-12-17 한남대학교 산학협력단 Preparation of nanospheres composed of biocompatible polymers using polymer melt process for drug delivery and nanospheres thereof
NZ580972A (en) 2007-06-04 2012-02-24 Egalet Ltd Controlled release pharmaceutical compositions for prolonged effect
US7940978B2 (en) * 2007-06-05 2011-05-10 General Electric Company Automatic characterization of cellular motion
US8501230B2 (en) * 2007-12-03 2013-08-06 Trilogic Pharma Llc Self solidifying bioerodible barrier implant
TWI454288B (en) 2008-01-25 2014-10-01 Gruenenthal Chemie Pharmaceutical dosage form
JP5569398B2 (en) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー/エス Apparatus for facilitating hemostasis and / or wound healing
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
EP2285214B1 (en) * 2008-06-10 2012-05-16 Teva Pharmaceutical Industries Ltd. Rasagiline soft gelatin capsules
ES2462090T5 (en) 2008-06-16 2017-07-12 Pfizer Inc. drug loaded polymeric nanoparticles and methods of manufacture and use thereof
WO2010005726A2 (en) 2008-06-16 2010-01-14 Bind Biosciences Inc. Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
WO2010005725A2 (en) 2008-06-16 2010-01-14 Bind Biosciences, Inc. Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
US20110250274A1 (en) * 2008-09-19 2011-10-13 Shaked Ze Ev Estriol formulations
US8563041B2 (en) * 2008-12-12 2013-10-22 Bind Therapeutics, Inc. Therapeutic particles suitable for parenteral administration and methods of making and using same
WO2010075072A2 (en) 2008-12-15 2010-07-01 Bind Biosciences Long circulating nanoparticles for sustained release of therapeutic agents
CA2751627A1 (en) 2009-02-06 2010-08-12 Egalet Ltd. Pharmaceutical compositions resistant to abuse
AU2010211220B2 (en) 2009-02-06 2013-08-01 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
EP2456424B1 (en) 2009-07-22 2013-08-28 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
PE10672012A1 (en) 2009-07-22 2012-09-05 Gruenenthal Chemie Form of controlled release dosage extruded by hot melt
WO2011041414A1 (en) 2009-09-30 2011-04-07 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
BR112012016021A2 (en) 2009-12-11 2018-05-02 Bind Biosciences Inc Stable formulations of therapeutic particulates for lyophilization
WO2011084513A2 (en) 2009-12-15 2011-07-14 Bind Biosciences, Inc. Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
EP2547371A1 (en) 2010-03-15 2013-01-23 Ferrosan Medical Devices A/S A method for promotion of hemostasis and/or wound healing
WO2011153334A2 (en) 2010-06-04 2011-12-08 Trilogic Pharma Llc Bioadhesive compositions for epithelial drug delivery
KR20130097202A (en) 2010-09-02 2013-09-02 그뤼넨탈 게엠베하 Tamper resistant dosage form comprising inorganic salt
JP5933553B2 (en) 2010-09-02 2016-06-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Abuse-resistant dosage form comprising an anionic polymer
EP2629760A4 (en) * 2010-10-22 2014-04-02 Bind Therapeutics Inc Therapeutic nanoparticles with high molecular weight copolymers
KR101775727B1 (en) 2010-12-15 2017-09-19 가톨릭대학교 산학협력단 Polyalkylenglycol-linker-polyester copolymer, method preparing the same and usage thereof
HUE034711T2 (en) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US20130225625A1 (en) * 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant pharmaceutical dosage form comprising nonionic surfactant
KR101455901B1 (en) * 2012-05-04 2014-11-03 성균관대학교산학협력단 Eutectic composition comprising celecoxib and poloxamer
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6394916B2 (en) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ/エス Dry hemostatic composition
EA201590165A1 (en) 2012-07-06 2015-08-31 Эгалет Лтд. Constraints abuse pharmaceutical composition for controlled release
CA2885193A1 (en) 2012-09-17 2014-03-20 Bind Therapeutics, Inc. Process for preparing therapeutic nanoparticles
EP3446685A1 (en) 2012-11-30 2019-02-27 Acura Pharmaceuticals, Inc. Self-regulated release of active pharmaceutical ingredient
JP6445537B2 (en) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Modified anti containing one or more particles (tamper-resistant) dosage forms
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
RU2016101631A (en) 2013-06-21 2017-07-26 Ферросан Медикал Дивайсиз А/С Extended vacuum dry composition and a syringe to save it
EP3052084A1 (en) * 2013-09-30 2016-08-10 Universiteit Gent Polyurethanes as oral drug delivery platform
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
US20150164807A1 (en) 2013-12-16 2015-06-18 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile manufactured by co-extrusion
JP6348616B2 (en) 2014-03-14 2018-06-27 ファイザー・インク Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using the same
US9642811B2 (en) 2014-03-26 2017-05-09 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release biphasic matrix solid dosage form
JP2017518980A (en) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Containing tapentadol, modified prevent immediate release capsule formulation
MX2016015417A (en) 2014-05-26 2017-02-22 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping.
US10182993B2 (en) * 2015-04-06 2019-01-22 Patheon Softgels Inc. Compositions for colonic delivery of drugs
KR20170139158A (en) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 Immediately released and prevent the tamper-resistant dosage form extraction solvent
EP3302382A4 (en) * 2015-05-29 2019-02-20 Allergan Inc Implant for treatment of an ocular condition
EP3135272A1 (en) * 2015-08-31 2017-03-01 Basf S.A. Compositions for mouth wash in the form of tablets
EP3184104B1 (en) * 2015-12-23 2018-09-12 Hexal AG Pharmaceutical composition of vortioxetine hydrobromide comprising vortioxetine hydrobromide in a polyethylene oxide matrix

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1018456A (en) 1972-06-26 1977-10-04 Hans Lowey Prolonged release lozenges
JPS5518694B2 (en) 1973-04-02 1980-05-21
US4330338A (en) * 1978-10-02 1982-05-18 Purdue Research Foundation Pharmaceutical coating composition, and preparation and dosages so coated
US4389393B1 (en) * 1982-03-26 1985-10-22
DE3320583A1 (en) * 1983-06-08 1984-12-13 Thomae Gmbh Dr K Novel pharmaceutical preparation forms of oral antidiabetic and process for their manufacture
AU591171B2 (en) 1983-11-02 1989-11-30 Alza Corporation Dispenser for delivering thermo-responsive composition
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
JPH0246008B2 (en) 1984-06-01 1990-10-12 Takada Seiyaku Kk Nifuejipinjizokuseiseizainoseizohoho
US5082655A (en) * 1984-07-23 1992-01-21 Zetachron, Inc. Pharmaceutical composition for drugs subject to supercooling
GB2170104A (en) 1985-01-30 1986-07-30 Warner Lambert Co Coated pharmaceutical dosage forms
IE59066B1 (en) 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
FI101344B1 (en) * 1988-03-31 1998-06-15 Tanabe Seiyaku Co A process for preparing a preparation for which the controlled release of a pharmaceutically active agent
EP0455648B1 (en) 1989-01-30 1993-03-10 Alza Corporation Dosage form for administering calcium antagonist
DK469989D0 (en) 1989-09-22 1989-09-22 Bukh Meditec pharmaceutical preparation
IT1237904B (en) * 1989-12-14 1993-06-18 Ubaldo Conte Tablets release at speed 'subsidiary of the active substances
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
GB9025372D0 (en) 1990-11-22 1991-01-09 Nat Res Dev Pharmaceutical dosage forms
US5881926A (en) 1993-03-11 1999-03-16 Taro Pharmaceutical Industries, Ltd. Pharmaceutical compositions in semisolid form and a device for administration thereof
US5656291A (en) * 1994-03-16 1997-08-12 Pharmacia & Upjohn Aktiebolag Controlled release preparation
JPH07100191A (en) 1993-10-06 1995-04-18 Daikyo Yakuhin Kogyo Kk Sustained release suppository
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5419917A (en) * 1994-02-14 1995-05-30 Andrx Pharmaceuticals, Inc. Controlled release hydrogel formulation
US6787156B1 (en) * 1994-02-23 2004-09-07 Bm Research A/S Controlled release composition
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
JP3161278B2 (en) 1995-04-26 2001-04-25 株式会社村田製作所 The dielectric ceramic composition
KR100459747B1 (en) 1996-05-20 2005-01-27 오쓰까 세이야꾸 가부시키가이샤 Roger Asian treatments
CA2262595C (en) * 1996-08-15 2005-10-18 Losan Pharma Gmbh Easy to swallow oral medicament composition
US6245357B1 (en) 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
AT267589T (en) 1998-04-03 2004-06-15 Egalet As A composition with controlled active ingredient release
JP4812167B2 (en) * 1999-02-12 2011-11-09 モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド Drug transport matrix, and creating and using the same
US6267985B1 (en) * 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6562375B1 (en) * 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
US6534085B1 (en) * 1999-09-23 2003-03-18 Bioresponse L.L.C. Phytochemicals for promoting weight loss
JP4310010B2 (en) * 1999-10-08 2009-08-05 トヨタ自動車株式会社 Unit cell
CA2392085A1 (en) 1999-11-15 2001-05-25 Smithkline Beecham Corporation Carvedilol methanesulfonate
US6352721B1 (en) 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6491949B2 (en) 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6378165B1 (en) * 2000-02-17 2002-04-30 Emerson Electric Co. Pull handle with interlocking mounting mechanism for wet/dry vacuum appliance
US20010036959A1 (en) * 2000-04-03 2001-11-01 Gabel Rolf Dieter Carvedilol-hydrophilic solutions
US20020054911A1 (en) * 2000-05-11 2002-05-09 Boehringer Mannheim Pharmaceutical Corporation-Sm Ithkline Beckman Corporation, Limited Partnershi Novel oral dosage form for carvedilol
US6488962B1 (en) * 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
WO2002065834A2 (en) 2000-10-24 2002-08-29 Smithkline Beecham Corporation Novel formulations of carvedilol
IN191028B (en) 2001-05-17 2003-09-13 Sun Pharmaceutical Ind Ltd Process for preparation of an oral controlled release pharmaceutical composition for once-a-day therapy for treatment and prophylaxis of cardiac and circulatory diseases
DE10131272B4 (en) * 2001-06-28 2006-03-30 Koenig & Bauer Ag turning device
DK1429734T3 (en) * 2001-09-21 2008-05-13 Egalet As Solid dispersions of carvedilol for the Controlled Release
US20040234602A1 (en) * 2001-09-21 2004-11-25 Gina Fischer Polymer release system
EP1429744A1 (en) * 2001-09-21 2004-06-23 Egalet A/S Morphine polymer release system
EP1429724B1 (en) * 2001-09-28 2013-11-06 McNeil-PPC, Inc. Dosage form containing a confectionery composition
AU2003225837B2 (en) * 2002-03-15 2008-11-06 Forest Laboratories Holdings Limited NE and 5-HT reuptake inhibitors for treating visceral pain syndromes
WO2004010970A1 (en) * 2002-07-29 2004-02-05 Alza Corporation Formulations and dosage forms for controlled delivery of topiramate
AT454886T (en) * 2003-03-26 2010-01-15 Egalet As Matrix preparations for the controlled administration of drug substances
WO2004041252A1 (en) * 2002-11-08 2004-05-21 Egalet A/S Controlled release carvedilol compositions
EP2301526B1 (en) * 2003-03-26 2016-03-23 Egalet Ltd. Morphine controlled release system
EP1646367A4 (en) 2003-07-21 2011-06-15 Nesher Solutions Ltd Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention
JP2007505921A (en) 2003-09-19 2007-03-15 ペンウェスト ファーマシューティカルズ カンパニー Delayed release dosage form
US20050163837A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Rosiglitazone formulations
CN101188999B (en) * 2005-06-03 2012-07-18 尹格莱特股份有限公司 A pharmaceutical delivery system for delivering active component dispersed in dispersion medium

Also Published As

Publication number Publication date
EP2186510A2 (en) 2010-05-19
WO2004084869A1 (en) 2004-10-07
CA2520312A1 (en) 2004-10-07
DE602004025159D1 (en) 2010-03-04
JP4989217B2 (en) 2012-08-01
EP1974726A3 (en) 2008-11-05
ES2307003T3 (en) 2008-11-16
US20100166866A1 (en) 2010-07-01
US20070042044A1 (en) 2007-02-22
EP1610768B1 (en) 2008-07-02
US8298581B2 (en) 2012-10-30
EP1610768A1 (en) 2006-01-04
EP1974726A2 (en) 2008-10-01
AT399538T (en) 2008-07-15
DE602004014747D1 (en) 2008-08-14
EP1974726B1 (en) 2010-01-13
CA2520312C (en) 2013-06-18
JP2006521301A (en) 2006-09-21
DK1610768T3 (en) 2008-09-22
EP2186510A3 (en) 2010-06-09
EP2186510B1 (en) 2013-07-10

Similar Documents

Publication Publication Date Title
DK1620118T3 (en) Reversible pegylated drugs
DE60016271D1 (en) drug delivery
NO329386B1 (en) Glucocorticoids-mimetic, pharmaceutical compositions and uses for the preparation of medikamenterfor treating disease
NO330755B1 (en) Compounds, pharmaceutical compositions and uses thereof
DE60233944D1 (en) Drug delivery systems
NO20020974L (en) pharmaceutical tramadol
NO20033384D0 (en) pharmaceutical formulations
NO20033556L (en) pharmaceutical formulations
DE60228464D1 (en) Drug delivery systems
DK1525200T3 (en) 2- (3-aminoaryl) amino-4-aryl-thiazoles for the treatment of disease
NO329384B1 (en) Aminoindazole derivatives, their preparation as well as pharmaceutical compositions and medicinal products containing the compounds
DK1038543T3 (en) Syringe for medical purposes
AT524069T (en) Synergistic fungicidal drug combinations
AT487470T (en) Gel stabilized drug nanoparticle compositions
DE602004026768D1 (en) Therapeutic anti-igfr1-antibody-combinations
PT1169298E (en) pharmaceutical compounds
DE60325567D1 (en) Matrix for the modified release of active substances
DK1651296T3 (en) medicament dispenser
DK1242055T3 (en) Hydrogelstyret dosage form drugs
DE50303080D1 (en) syringe pump
RU2003130471A (en) disposable syringe
ITMI20002556A1 (en) Use of organic compounds in the treatment of diseases
DE60325879D1 (en) self-closure cannula
EE200100714A (en) The pharmaceutical dosage forms methods pihustamissüsteemidja
NO20053277D0 (en) Short-acting pharmaceutical compositions.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties